STOCK TITAN

Brighthouse Fina Financials

BHFAN
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Brighthouse Fina (BHFAN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BHFAN FY2025

BHFAN’s thin equity on a massive asset base makes cash conversion and capital cushion more important than revenue.

From FY2023 to FY2025, reported earnings swung from -$1.2B to $331M, yet cumulative operating cash flow across those three years was still slightly negative at -$168M. At the same time, equity rebuilt from $4.9B to $6.8B against $241.8B of assets, so profit recovery has improved the buffer but has not removed the business’s sensitivity to relatively small balance-sheet moves.

The drop in debt-to-equity from 0.6x in FY2024 to 0.5x in FY2025 looks like deleveraging, but long-term debt stayed essentially flat near $3.2B. The ratio improved mainly because the equity base got larger, which is a different mechanic than paying debt down.

FY2025 cash of $5.4B exceeded long-term debt of $3.2B, so ordinary borrowings are not the main balance-sheet constraint. The bigger structural fact is liabilities of $235.0B sitting above only $6.8B of equity, which helps explain why returns on assets remained very small even after earnings turned positive.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 30 / 100
Financial Profile 30/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Brighthouse Fina's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
80

Brighthouse Fina's revenue surged 43.2% year-over-year to $6.8B, reflecting rapid business expansion. This strong growth earns a score of 80/100.

Leverage
93

Brighthouse Fina carries a low D/E ratio of 0.47, meaning only $0.47 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.

Returns
9

Brighthouse Fina generates a 4.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 9/100. This is down from 5.8% the prior year.

Piotroski F-Score Neutral
6/9

Brighthouse Fina passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
0.78x

For every $1 of reported earnings, Brighthouse Fina generates $0.78 in operating cash flow ($259.0M OCF vs $331.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.8B
YoY+43.2%
5Y CAGR-4.5%
10Y CAGR-2.7%

Brighthouse Fina generated $6.8B in revenue in fiscal year 2025. This represents an increase of 43.2% from the prior year.

EBITDA
N/A
Net Income
$331.0M
YoY+15.7%
10Y CAGR-11.5%

Brighthouse Fina reported $331.0M in net income in fiscal year 2025. This represents an increase of 15.7% from the prior year.

EPS (Diluted)
$5.71
YoY+23.1%

Brighthouse Fina earned $5.71 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$5.4B
YoY+6.8%
5Y CAGR+5.6%
10Y CAGR+13.1%

Brighthouse Fina held $5.4B in cash against $3.2B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
57M
YoY-2.5%
5Y CAGR-8.3%

Brighthouse Fina had 57M shares outstanding in fiscal year 2025. This represents a decrease of 2.5% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
4.9%
YoY-1.2pp
5Y CAGR+17.4pp
10Y CAGR-7.7pp

Brighthouse Fina's net profit margin was 4.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.

Return on Equity
4.9%
YoY-0.9pp
5Y CAGR+10.8pp
10Y CAGR-1.8pp

Brighthouse Fina's ROE was 4.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$102.0M
YoY-59.2%
5Y CAGR-26.4%

Brighthouse Fina spent $102.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 59.2% from the prior year.

Capital Expenditures
N/A

BHFAN Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $1.5B-9.6% $1.7B-7.0% $1.8B+108.5% $871.0M-63.6% $2.4B+98.3% $1.2B-40.3% $2.0B+41.4% $1.4B
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $114.0M-1.7% $116.0M+16.0% $100.0M-2.9% $103.0M-20.8% $130.0M+38.3% $94.0M-7.8% $102.0M+1.0% $101.0M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $38.0M0.0% $38.0M0.0% $38.0M0.0% $38.0M0.0% $38.0M0.0% $38.0M0.0% $38.0M0.0% $38.0M
Income Tax -$222.0M-1950.0% $12.0M-88.5% $104.0M+1200.0% $8.0M+109.1% -$88.0M-154.3% $162.0M+1520.0% $10.0M+150.0% -$20.0M
Net Income -$766.0M-2288.6% $35.0M-92.7% $479.0M+463.5% $85.0M+131.7% -$268.0M-147.1% $569.0M+223.3% $176.0M+417.6% $34.0M
EPS (Diluted) $-13.82 N/A $7.89+673.5% $1.02+120.2% $-5.04 N/A $2.47+1958.3% $0.12

BHFAN Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $236.8B-2.1% $241.8B-1.2% $244.7B+0.8% $242.6B+3.4% $234.7B-1.6% $238.5B-2.7% $245.2B+3.3% $237.4B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $4.9B-8.9% $5.4B-18.5% $6.6B+19.2% $5.5B+18.7% $4.7B-7.5% $5.0B-10.4% $5.6B+26.8% $4.4B
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $231.2B-1.6% $235.0B-1.4% $238.3B+0.6% $236.9B+3.3% $229.4B-1.8% $233.5B-2.5% $239.6B+2.7% $233.2B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $3.2B0.0% $3.2B0.0% $3.2B0.0% $3.2B0.0% $3.2B0.0% $3.2B0.0% $3.2B0.0% $3.2B
Total Equity $5.6B-17.8% $6.8B+6.4% $6.4B+12.2% $5.7B+8.3% $5.2B+5.6% $5.0B-10.2% $5.5B+33.4% $4.1B
Retained Earnings -$1.5B-111.7% -$686.0M+16.6% -$823.0M+36.8% -$1.3B+6.1% -$1.4B-23.9% -$1.1B+37.5% -$1.8B+9.0% -$2.0B

BHFAN Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$221.0M-7266.7% -$3.0M-102.6% $117.0M+11800.0% -$1.0M-100.7% $146.0M+223.7% -$118.0M-591.7% $24.0M-92.8% $334.0M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$485.0M+62.6% -$1.3B-194.5% $1.4B+1125.0% $112.0M-80.1% $563.0M+257.7% -$357.0M-174.6% -$130.0M+88.0% -$1.1B
Financing Cash Flow $226.0M+182.5% $80.0M+118.9% -$423.0M-155.5% $762.0M+170.1% -$1.1B-888.2% -$110.0M-108.5% $1.3B-5.2% $1.4B
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $0 $0 $0-100.0% $43.0M-27.1% $59.0M-1.7% $60.0M-6.3% $64.0M0.0% $64.0M

BHFAN Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin -50.2%-52.2pp 2.1%-24.3pp 26.4%+16.6pp 9.8%+21.0pp -11.2%-58.4pp 47.2%+38.5pp 8.7%+6.3pp 2.4%
Return on Equity -13.8%-14.3pp 0.5%-7.0pp 7.5%+6.0pp 1.5%+6.6pp -5.1%-16.6pp 11.5%+8.3pp 3.2%+2.4pp 0.8%
Return on Assets -0.3%-0.3pp 0.0%-0.2pp 0.2%+0.2pp 0.0%+0.1pp -0.1%-0.3pp 0.2%+0.2pp 0.1%+0.1pp 0.0%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.57+0.1 0.47-0.0 0.50-0.1 0.56-0.0 0.60-0.0 0.64+0.1 0.57-0.2 0.76
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

Brighthouse Fina (BHFAN) reported $6.8B in total revenue for fiscal year 2025. This represents a 43.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Brighthouse Fina (BHFAN) revenue grew by 43.2% year-over-year, from $4.7B to $6.8B in fiscal year 2025.

Yes, Brighthouse Fina (BHFAN) reported a net income of $331.0M in fiscal year 2025, with a net profit margin of 4.9%.

Brighthouse Fina (BHFAN) reported diluted earnings per share of $5.71 for fiscal year 2025. This represents a 23.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Brighthouse Fina (BHFAN) had $5.4B in cash and equivalents against $3.2B in long-term debt.

Brighthouse Fina (BHFAN) had a net profit margin of 4.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Brighthouse Fina (BHFAN) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Brighthouse Fina (BHFAN) generated $259.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Brighthouse Fina (BHFAN) had $241.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Brighthouse Fina (BHFAN) spent $102.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Brighthouse Fina (BHFAN) had 57M shares outstanding as of fiscal year 2025.

Brighthouse Fina (BHFAN) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Brighthouse Fina (BHFAN) had a return on assets of 0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Brighthouse Fina (BHFAN) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Brighthouse Fina (BHFAN) has an earnings quality ratio of 0.78x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Brighthouse Fina (BHFAN) scores 30 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top